Both in Pharmaceuticals
RenovoRx vs Nomad Power Solutions
Over the past year RNXT returned −29.0% and NMAD returned −10.5%; their daily moves had a correlation of 0.12.
RNXT −29.0% NMAD −10.5%Growth of $1, one year, split-adjusted
| Metric | RNXT | NMAD |
|---|---|---|
| Price | $1.25 | $3.17 |
| Market cap | $56.4M | $51.0M |
| Today | −6.01% | −10.96% |
| 1 month | −20.9% | −23.1% |
| 6 months | +41.2% | — |
| Year to date | +48.8% | — |
| 1 year | +23.2% | — |
| Revenue growth (YoY) | +115.4% | — |
| Gross margin | 84.3% | — |
| Net margin | −320.2% | — |
| P/E (TTM) | — | — |
| Price / sales | 28.5× | — |
| Net cash | $9.5M | — |
| Dividend yield | — | — |
| Volatility (60d) | 108.7% | — |
| Short % of float | 2.0% | 11.0% |
| Next earnings | — | — |
Shading marks the stronger figure where one clearly exists (lower is better for valuation and volatility).